To various degrees, psychopharmacologic medications are associated with side effects. Despite improvements in newer psychopharmacologic medication, monitoring for side effects remains important for individuals with mental retardation and developmental disabilities for a number of reasons, of which p
Overview: Psychopharmacology in mental retardation and developmental disabilities
โ Scribed by Schroeder, Stephen R.
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 76 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1080-4013
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Beta-adrenergic-blocking medications have been hypothesized to benefit persons with a wide variety of neuropsychiatric disorders. Research supports their use in only three areas, however: anxiety disorders with prominent physiological signs, impulsive aggression, and neuroleptic-induced akathisia (N
Treatment for aberrant behavior in persons diagnosed with developmental disabilities typically involves either behavioral interventions or medication. Often, the treatment is a combination of the two. Schroeder and coworkers Adv Learn Behav Disabil 2:179-225) outlined criteria for the evaluation of